NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating)’s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as $15.23 and last traded at $16.22, with a volume of 128594 shares changing hands. The stock had previously closed at $16.89.
Analyst Ratings Changes
Several analysts have issued reports on NXGN shares. Piper Sandler decreased their price objective on shares of NextGen Healthcare from $20.00 to $17.00 in a research note on Thursday. Stephens began coverage on NextGen Healthcare in a research report on Tuesday, April 11th. They issued an “overweight” rating and a $24.00 price objective on the stock. TheStreet lowered NextGen Healthcare from a “b-” rating to a “c” rating in a research note on Tuesday. Finally, StockNews.com started coverage on shares of NextGen Healthcare in a research note on Thursday. They set a “buy” rating for the company. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.50.
NextGen Healthcare Stock Performance
The firm’s fifty day moving average price is $17.12 and its 200 day moving average price is $18.30. The firm has a market cap of $1.05 billion, a P/E ratio of 45.23 and a beta of 1.04. The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.53 and a current ratio of 2.53.
Institutional Trading of NextGen Healthcare
About NextGen Healthcare
NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.
- Get a free copy of the StockNews.com research report on NextGen Healthcare (NXGN)
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.